Vagrecor 160 mg filmomhulde tabletten
As listed in the register: Vagrecor 160 mg filmomhulde tabletten
160 mg · filmomhulde tablet
- Prescription only
- Heart, blood pressure and circulation
- Active substance
- Valsartan
- Made by
- Laboratorios Liconsa S.A.
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
How it works
This product’s leaflet is published as a scanned document. This section quotes the US prescribing label for the same active substance (valsartan). It describes the substance, not this Bulgarian product — its uses and doses can differ.
Angiotensin II is formed from angiotensin I in a reaction catalyzed by angiotensin-converting enzyme (ACE, kininase II).
Angiotensin II is the principal pressor agent of the renin-angiotensin system, with effects that include vasoconstriction, stimulation of synthesis and release of aldosterone, cardiac stimulation, and renal reabsorption of sodium.
In vitro metabolism studies involving recombinant CYP 450 enzymes indicated that the CYP 2C9 isoenzyme is responsible for the formation of valeryl-4-hydroxy valsartan.
Effect of Food With the tablet, food decreases the exposure (as measured by AUC) to valsartan by about 40% and peak plasma concentration (C max ) by about 50%.
Quoted from the prescribing label, sections “Mechanism of Action” and “Pharmacokinetics”. DailyMed · 2026-06-25
Safety of the active substance
This product’s leaflet is published as a scanned document. This section quotes the US prescribing label for the same active substance (valsartan). It describes the substance, not this Bulgarian product — its uses and doses can differ.
WARNING: FETAL TOXICITY.
- Do not use in patients with known hypersensitivity to any component.
- Do not coadminister aliskiren with valsartan tablets in patients with diabetes [see Drug Interactions ( 7.3 )].
- Known hypersensitivity to any component.
The most common reasons for discontinuation of therapy with valsartan were headache and dizziness.
Quoted from the US prescribing label for the same active substance. Your own pack’s leaflet is the authority for your product. DailyMed
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
United States31 matching products
Bulgaria10 matching products
- Diovan 160 mg · film-coated tablets2 makers
- Sarteg 160 mg film-coated tablets · film coated tablet
- Suvartar 160 mg · film - coated tablets
- Valdipin 160 mg · film - coated tablets
- Valsacor 160 mg · film - coated tablets
- Valsarcon 160 mg · film - coated tablets
- Valsavil 160 mg · film - coated tablets
- Valtensin 160 mg · film-coated tablets
Spain35 matching products
- DIOVAN 160 mg valsartan · comprimido recubierto con película6 makers
- ARALTER 160 mg · comprimido recubierto con película
- KALPRESS 160mg · comprimido recubierto con película
- MITEN 160 mg · comprimido recubierto con película
- PRESAR 160 mg · comprimido bucodispersable
- VALS 160 mg valsartan · comprimido recubierto con película
- VALSARTAN ALMUS 160 mg valsartan · comprimido recubierto con película
- VALSARTAN ALTER 160 mg · comprimido recubierto con película
France11 matching products
- TAREG 160 mg · comprimé pelliculé
- VALSARTAN ARROW LAB 160 mg · comprimé pelliculé sécable
- VALSARTAN BIOGARAN 160 mg · comprimé pelliculé sécable
- VALSARTAN CRISTERS 160 mg · comprimé pelliculé sécable
- VALSARTAN EG 160 mg · comprimé pelliculé sécable
- VALSARTAN EVOLUGEN 160 mg · comprimé pelliculé sécable
- VALSARTAN SANDOZ 160 mg · comprimé pelliculé
- VALSARTAN TEVA 160 mg · comprimé pelliculé sécable
Canada9 matching products
SwitzerlandNo exact match for this strength and form
Details
| Made by | Laboratorios Liconsa S.A. |
|---|---|
| Active substance | Valsartan |
| Used in | Heart, blood pressure and circulation |
| Strength | 160 mg |
| Form | filmomhulde tablet |
| Classification | C09CA03 · Heart, blood pressure and circulation |
| Route | oraal gebruik |
| Dispensing (as stated by the register) | Uitsluitend recept |
| RVG | 103976 |
Source: Geneesmiddeleninformatiebank · 2026-09-30 · not reviewed by a clinician
Bron: College ter Beoordeling van Geneesmiddelen (CBG). De Rijksoverheid is het niet automatisch eens met de inhoud van deze site. Reuse terms: CC0 1.0 (CBG website).
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.